Similarly, in AD patients were shown reduced both NPY receptor densities in hippocampal and cortical regions (Martel et al., 1990) and NPY levels in plasma and cerebrospinal fluid samples (Nilsson et al., 2001). The gene discussed is NPY; the disease is Alzheimer disease.